Literature DB >> 1899464

Increase in rubella and congenital rubella syndrome--United States, 1988-1990.

.   

Abstract

In 1988, health departments in the United States reported an all-time low of 225 cases of rubella. However, in 1989, the number of reported cases increased nearly twofold, and in 1990, an additional threefold. As of January 4, 1991, a provisional total of 1093 cases (0.4 cases per 100,000 population) had been reported to the National Notifiable Disease Surveillance System (NNDSS) for 1990--the highest total since 1982 (Figure 1). This report summarizes the increase in rubella and congenital rubella syndrome (CRS) since 1988.

Entities:  

Mesh:

Year:  1991        PMID: 1899464

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  9 in total

1.  Evaluation of antibodies against a rubella virus neutralizing domain for determination of immune status.

Authors:  P Cordoba; A Lanoel; S Grutadauria; M Zapata
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

2.  Highlights of historical events leading to national surveillance of vaccination coverage in the United States.

Authors:  Philip J Smith; David Wood; Paul M Darden
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

Review 3.  Religious barriers to measles vaccination.

Authors:  Eric Wombwell; Mary T Fangman; Alannah K Yoder; David L Spero
Journal:  J Community Health       Date:  2015-06

4.  Economic benefits of a routine second dose of combined measles, mumps and rubella vaccine in Canada.

Authors:  M Rivière; R Tretiak; C Levinton; C Fitzsimon; C Leclerc
Journal:  Can J Infect Dis       Date:  1997-09

5.  Seroprevalence of rubella among women of childbearing age in Switzerland.

Authors:  J Zufferey; P Jacquier; S Chappuis; O Spinnler; P Hohlfeld; P L Zuber; J Bille
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-08       Impact factor: 3.267

6.  Rubella antibody levels in school-aged children in Newfoundland: Implications for a two-dose rubella vaccination strategy.

Authors:  S Ratnam; R West; V Gadag; B Williams; E Oates
Journal:  Can J Infect Dis       Date:  1997-03

7.  The incidence of rubella virus infections in Switzerland after the introduction of the MMR mass vaccination programme.

Authors:  L Matter; F Bally; D Germann; K Schopfer
Journal:  Eur J Epidemiol       Date:  1995-06       Impact factor: 8.082

8.  Prevention of infection in pregnancy.

Authors:  W J Ledger; D Skupski
Journal:  Infect Dis Obstet Gynecol       Date:  1997

Review 9.  Molecular biology of rubella virus.

Authors:  T K Frey
Journal:  Adv Virus Res       Date:  1994       Impact factor: 9.937

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.